SCHEMBL5689338

SCHEMBL5689338

NC[C@@H](CO)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.50
EPHX1 P07099 1/20 0.48
ALPI P09923 1/20 0.45
PKM P14618 1/20 0.45
PTGS1 P23219 1/20 0.45
XIAP P98170 1/20 0.45
SLC7A5 Q01650 1/20 0.45
SLC6A2 P23975 2/20 0.45
TAAR1 Q96RJ0 2/20 0.45
MAOA P21397 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
SIGMAR1 Q99720 1/20 0.45
CYP2A6 P11509 1/20 0.45
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
CYP1A2 P05177 1/20 0.43
LAP3 P28838 3/20 0.42
ANPEP P15144 2/20 0.42
LOXL2 Q9Y4K0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL353179 1.00 TRPA1 (0.50) TRPA1EPHX1ALPIPKMPTGS1
SCHEMBL29822049 1.00 TRPA1 (0.50) TRPA1EPHX1ALPIPKMPTGS1
SCHEMBL5161982 0.86 TRPA1 (0.58) TRPA1EPHX1ALPIPKMPTGS1
SCHEMBL13721525 0.86 TRPA1 (0.58) TRPA1EPHX1ALPIPKMPTGS1
SCHEMBL516032 0.86 EPHX1 (0.56) EPHX1ALPIPKMPTGS1XIAP
SCHEMBL6563096 0.86 EPHX1 (0.56) EPHX1ALPIPKMPTGS1XIAP
SCHEMBL8895212 0.83 SLC6A2 (0.47) TRPA1EPHX1ALPIPKMPTGS1
SCHEMBL8895209 0.83 SLC6A2 (0.47) TRPA1EPHX1ALPIPKMPTGS1
SCHEMBL27754378 0.83 TRPA1 (0.47) TRPA1EPHX1ALPIPKMPTGS1
SCHEMBL27482362 0.83 TRPA1 (0.47) TRPA1EPHX1ALPIPKMPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0982026-B1 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers HOFFMANN LA ROCHE (CH) 2006-05-17 EP disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 US disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 EP disclosed
CN-1128534-A Monomeric and multimeric compounds with improved relaxivity BRACCO INT BV (NL) 1996-08-07 CN disclosed